Felbatol and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Felbatol (felbamate), especially for people who are female, 20-29 old, also take Depakote, and have Arthritis.

The phase IV clinical study analyzes which people have Weight increased when taking Felbatol. It is created by eHealthMe based on reports of 877 people who have side effects when taking Felbatol from the FDA, and is updated regularly.

What is Felbatol?

Felbatol has active ingredients of felbamate. It is often used in epilepsy. eHealthMe is studying from 906 Felbatol users. Check the latest studies of Felbatol.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,954 conditions by eHealthMe. Check the latest studies of Weight increased.

On May, 11, 2026

877 people reported to have side effects when taking Felbatol.
Among them, 18 people (2.05%) have Weight increased.

Among these 18 people:

What is the gender of people who have Weight increased when taking Felbatol? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Weight increased when taking Felbatol? *

What are other drugs people take besides Felbatol? *

What are other side effects people have besides Weight increased? *

Memory Loss: 5 people, 27.78%
Headache (pain in head): 4 people, 22.22%
Fatigue (feeling of tiredness): 4 people, 22.22%
Balance Disorder: 4 people, 22.22%
Confusional State: 3 people, 16.67%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 16.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 16.67%
Fall: 3 people, 16.67%
Drug Ineffective: 3 people, 16.67%
Drowsiness: 3 people, 16.67%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 16.67%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 11.11%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
Complex Partial Seizures (epileptic seizure): 2 people, 11.11%
Rickets (softening of bones): 1 person, 5.56%
Myoclonic Epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs): 1 person, 5.56%
Menstrual Disorder (disease of menstrual cycle): 1 person, 5.56%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 5.56%
High Blood Pressure: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Felbatol and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Felbatol:

Felbatol (906 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

Browse all side effects of Felbatol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,954 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on felbamate (the active ingredients of Felbatol) and Felbatol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.